(Q34632441)

3 August 2017

1 reference

title

Is Th1 the solution for Th2 in asthma? (English)

1 reference

3 August 2017

0 references

Tournoy KG

1

1 reference

3 August 2017

Kips JC

series ordinal

2

1 reference

3 August 2017

Pauwels RA

series ordinal

3

1 reference

3 August 2017

language of work or name

1 reference

1 January 2002

1 reference

Clinical & Experimental Allergy

3 August 2017

1 reference

3 August 2017

32

1 reference

3 August 2017

1

1 reference

3 August 2017

17-29

1 reference

Mucosal inflammation in asthma

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Immunologic basis of antigen-induced airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Transfer of allergic airway responses with serum and lymphocytes from rats sensitized to dust mite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Commitment factors for T helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

A mite subversive: cleavage of CD23 and CD25 by Der p 1 enhances allergenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The role of CD40 ligand in costimulation and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Attenuation of allergic airway inflammation in IL-4 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Essential role of Stat6 in IL-4 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The role of IL-13 and its receptor in allergy and inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Atopic disorders: a default pathway in the absence of infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

A genome-wide search for quantitative trait loci underlying asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The effects of inhaled interferon gamma in normal human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The regulation of IL-12: its role in infectious, autoimmune, and allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-12 as a target for modulation of the inflammatory response in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Recombinant interleukin 12 cures mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Gender differences in the polysomnographic features of obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The toxicology of interleukin-12: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Counterbalancing of TH2-driven allergic airway inflammation by IL-12 does not require IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Immunosuppressive and anti-inflammatory properties of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Ovalbumin (OVA) and Mycobacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper (Th) cells toward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

21 January 2018

CpG DNA as a Th1 trigger

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Oligonucleotide therapy of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Mechanisms of specific immunotherapy of allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Conditions that induce tolerance in mature CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Peptide modulation of allergen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Induction of non-responsiveness in human allergen-specific type 2 T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

CD80 costimulation is essential for the induction of airway eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Induction of Th2 cell tolerance to a soluble antigen by blockade of the LFA-1-dependent pathway prevents allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

T cells and chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Soluble interleukin-4 receptor (sIL-4R) in allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

An immune cell-selective interleukin 4 agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Role of IL-13 in CD4 T cell-dependent IgE production in atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Requirement for IL-13 independently of IL-4 in experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-10: an anti-inflammatory cytokine with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Haplotype associated with low interleukin-10 production in patients with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

Bacterial DNA causes septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01279.X

10.1046/J.0022-0477.2001.01279.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference